Share on StockTwits

Several investment firms have updated their stock ratings and price targets on shares of Smith & Nephew plc (LON: SN) in the last week:

  • Smith & Nephew plc had its “hold” rating reaffirmed by analysts at Berenberg Bank. They now have a GBX 920 ($15.27) price target on the stock.
  • Smith & Nephew plc had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a GBX 1,230 ($20.41) price target on the stock.
  • Smith & Nephew plc had its “hold” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 1,000 ($16.59) price target on the stock.
  • Smith & Nephew plc was downgraded by analysts at Jefferies Group to a “hold” rating. They now have a GBX 1,000 ($16.59) price target on the stock.

Smith & Nephew plc (LON:SN) opened at 1047.00 on Thursday. Smith & Nephew plc has a 52 week low of GBX 737.50 and a 52 week high of GBX 1136.00. The stock’s 50-day moving average is GBX 1040. and its 200-day moving average is GBX 981.7. The company’s market cap is £9.360 billion.

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (LON:SN) and advanced wound management.

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with Analyst Ratings Network's FREE daily email newsletter.